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Abstract
Introduction
We investigated the role of pancreatic stone protein (PSP) in predicting the occurrence of in-
fection in the postoperative course of cardiac surgery patients. Several biomarkers indicat-
ing the presence of inflammation and infection are available in the clinical routine; yet, their
utility in the postoperative course of patients following cardiac surgery remains uncertain.
Moreover, cardiopulmonary bypass, also referred to as “on-pump surgery”, increases the
susceptibility to an exaggerated inflammatory state. However, the impact of such extracor-
poreal circulation on circulating PSP levels remains poorly understood.
Methods
In a prospective cohort of unselected patients undergoing cardiac surgery, we set out to elu-
cidate the diagnostic accuracy of serum PSP levels as opposed to canonical biomarkers
(CRP, WBC) of inflammation to discriminate between the presence of infection and surgical
trauma,. In addition, we investigated whether the biomarkers were influenced by the surgi-
cal technique employed, i.e. on-pump vs. off-pump and minimally invasive surgery vs. ster-
notomy. Levels of circulating PSP and routine inflammatory biomarkers (CRP, WBC) were
measured in samples taken from 120 patients at baseline as well as at postoperative day
1–3.
Results
Univariate analysis showed that among the biomarkers investigated, only PSP levels had
discriminatory power to differentiate infection from surgical trauma in the postoperative
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course of the entire cohort of patients following cardiac surgery. With regard to cardiac sur-
gical interventions, there was no significant association between the absence or presence
of extracorporeal circulation and PSP levels. However, there was a significant difference in
the slope of the rise of postoperative PSP between minimally invasive surgery as opposed
to patients subjected to sternotomy.
Conclusion
In an unselected population of cardiac surgery patients, post-operative serum PSP levels
were significantly associated with the presence of infection in both the on-pump and off-
pump setting. Of note, the surgical technique employed (sternotomy vs. minimally invasive
approach) had a significant impact on postoperative PSP levels.
Introduction
Despite decades of intensive research and constant evolution of clinical experience, mortality
and morbidity associated with sepsis remains substantial and is higher than that associated
with heart failure or many cancers in the range of up to 18–30% [1, 2]. A major factor in the
poor clinical outcome of patients presenting with sepsis even under the best possible care in
the ICU is the lack of reliable diagnostic tools in the timely identification of patients needing
emergency medical care [3]. In a clinical syndrome similar to sepsis, albeit in the absence of
bacterial infection as an underlying trigger, designated as the systemic inflammatory response
syndrome (SIRS), release of endogenous danger signals or so-called damage-associated molec-
ular patterns (DAMPS) as a result of tissue injury activates a set of pro-inflammatory circuits
reminiscent of those described in septic shock [4, 5]. SIRS might present in a subclinical form
or progress to a fulminant state with multiorgan failure. In patients undergoing cardiac sur-
gery, use of extracorporeal circulation is inevitably associated with the occurrence of some de-
gree of exaggerated inflammation that is added to the surgical stress inherent to the procedure
itself [6, 7]. The degree of such sterile inflammation is associated with an increased rate of mor-
bidity and hence poor clinical outcome [8, 9]. Consequently, there is an urgent need for ade-
quate biomarkers to differentiate patients with postoperative infection from those with reactive
inflammation at an early time point. This may help clinical decision making at the incipient
stage of the disease, thus potentially increasing the opportunity for effective therapeutic inter-
vention. The major challenge clinicians are facing in the development of accurate diagnostic
and prognostic biomarkers in septic patients compared to other clinical emergencies relates to
the complexity of the underlying disease process. Consequently, more than 3000 types of bio-
markers have been suggested as potential diagnostic tools in septic patients, while, by compari-
son, there are only about 15 biomarkers available for the diagnosis of acute myocardial
infarction [3].
However, a clear diagnostic algorithm for timely identification of patients at risk for a life
threatening maladaptive inflammatory response has not yet emerged. For instance, implemen-
tation of procalcitonin (PCT)-based protocols has proven useful in supporting clinical decision
making with regard to tailoring the duration of antibiotic treatment in septic ICU patients but
does not allow for early diagnosis or prognostic stratification of these patients [10]. Circulating
levels of pro-inflammatory cytokines help identify patients at risk of early deterioration, but
their usefulness in clinical diagnosis is limited by their narrow time frame of expression [11].
Against this background, the emergence of pancreatic stone protein/regenerating protein
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(PSP/reg) as a novel diagnostic and prognostic biomarker in a broad range of septic ICU pa-
tients is a promising development [12–14]. Originally described as a protein constitutively se-
creted by pancreatic acinar cells, insights from recent studies on the role of PSP as a biomarker
for SIRS and sepsis in a heterogeneous patient population has led to an appreciation of a much
broader functional scope of this protein. The initial circulating levels of this protein enable
prognostic assessment of the evolution of the disease in patients suffering from SIRS or sepsis.
For instance, in a prospective study it was shown that PSP, measured within 24 h after admis-
sion to ICU, performed much better in predicting the risk for mortality in patients presenting
with severe sepsis or septic shock compared to canonical markers of ongoing inflammation
[14]. Similarly, a role for predicting outcome in patients with ventilator-associated pneumonia
or COPD with superimposed bacterial infection has been suggested [13]. In another study,
measures of PSP were closely correlated with the severity of infection in trauma patients [15].
Moreover, data suggest that initial circulating PSP levels might be clinically useful in distin-
guishing between patients suffering from sepsis and those with a non-infective inflammatory
response [14].
The molecular mechanism by which PSP reacts to infection is not fully understood. In con-
trast to many products of the pancreatic acinar cell, which are stimulated by hormones, the
synthesis and secretion of PSP, and of a few other proteins, is also stimulated by cytokines and
other signals. Hence, the pancreas is also recognized as an acute phase organ [16]. These pro-
teins are found in pancreatic juice but are also diverted to the interstitium and end up in the
bloodstream. We have previously shown by FACS-analysis of blood-derived leukocytes, that
PSP interacts with granulocytes and propagates their activation (15). A detailed mechanism of
how PSP affects the innate immune system remains to be shown.
In the present study, we sought to determine whether at an incipient stage of the disease,
PSP predicts the onset of infection in the early postoperative course of patients undergoing car-
diac surgery. Furthermore, we wanted to elucidate the impact of extracorporeal circulation and
of surgical techniques on circulating PSP levels and the ability of PSP to discriminate sterile
systemic inflammation from infection. To pursue these aims, we prospectively measured base-
line and early postoperative serum PSP levels at day 1–3 in 120 unselected patients who under-
went cardiac surgery and closely monitored their postoperative course with respect to onset of
clinically manifest infection.
Materials and Methods
Participants
Approval for the current study was obtained from the Ethics Committee of the University of
Zurich. Calculated sample size was estimated a priori by GPOWER 3.1 [17] resulting in a re-
quested number of approximately 110 patients (given α = 0.05, power = 0.9, effect size = 0.25).
Between May and December 2012, after giving written informed consent, each patient older
than 18 years of age (N = 145) awaiting elective cardiac surgery was included, in the study on
the day of admission to hospital (usually one day before surgery). Exclusion criteria were age<
18 years and preexistent infections, such as urinary tract infections, endocarditis, and pneumo-
nia or wound infections. Out of the 145 patients, 120 patients who fulfilled the inclusion crite-
ria were enrolled in this prospective, single-center cohort study.
Measurement of serum/plasma biomarker concentration
Biomarkers of concern for the current study (PSP, CRP, WBC) were obtained from the pre-
and postoperative routine blood samples. CRP and WBC were determined by standard proce-
dures. PSP was measured as described previously [15]. PSP measurements were performed by
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an experienced technician at the University Hospital of Zurich. All clinicians involved in the
study were blinded to PSP results whereas they were aware of WBC and CRP values.
Preoperative data
At admission, baseline blood samples were taken for analysis of PSP, CRP, WBC and other pre-
operative routine parameters. Data on age (years), gender (male/female), height (in cm), weight
(in kg), BMI, diabetes mellitus (y/n) and the Euroscore II (%) were collected.
Operative data
The different procedures were classified under five categories (isolated bypass surgery, isolated
valve surgery, aortic surgery, combined procedures, others). The surgical approach was differ-
entiated in sternotomy versus minimally invasive procedures. Further variables were heart-
lung machine (HLM) (y/n), time of extracorporeal circulation (EEC in minutes), time of cardi-
ac ischemia (in minutes) and total surgery time. Intraoperative measurement of PSP was
not performed.
Postoperative data
First postoperative blood for quantifying the postoperative levels of PSP, CRP and WBC was
obtained within 24 hours after each procedure followed by further daily blood samples until
patient’s discharge. Whenever postoperative infections or sepsis were suspected, we used the
definition of infection and sepsis as defined in Levy et al. [18].
Endpoints
• Primary endpoint: time course of PSP serum levels before and after elective cardiac surgery
(baseline, 24h/48h/72h postoperative).
• Secondary endpoints:
• time course of PSP serum levels in absence/presence of infection compared with time
course of routine markers of inflammation (CRP, WBC)
• time course of PSP serum levels in absence/presence of cardiopulmonary bypass compared
with time course of routine markers of inflammation (CRP, WBC)
• time course of PSP levels as related to the surgical technique employed (sternotomy/mini-
mally invasive approach) compared with time course of routine markers of inflammation
(CRP, WBC)
Statistical analysis
Discrete values are expressed as counts (percentages) and continuous variables as means (SD)
or medians (IQR) as appropriate. Loge transformation of PSP, CRP andWBC values was car-
ried out to reach normal distribution of data for parametric analysis. Comparison of baseline
levels of inflammatory markers investigated (PSP, CRP, WBC) with clinical characteristics was
carried out with one-way ANOVA. Receiver operating characteristics analysis was employed at
postoperative day 1–3 for evaluation of the diagnostic performance of PSP, CRP and WBC for
prediction of the clinical outcome infection. Values of the area under the curve (AUC) are re-
ported with corresponding 95% CI. Cut-off points for PSP levels at postoperative day 2 were se-
lected giving equal weight to sensitivity and specificity. To delineate the time course of PSP
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following cardiac surgery, a linear mixed effects regression model with random intercepts was
employed with determination of an interaction between group (infection yes/no) and time. In
a second step, a split-plot ANOVA design was employed to adjust for associations of PSP levels
with baseline characteristics (age, diabetes). Univariate binary logistic regression analysis was
used to test PSP, CRP andWBC as predictors for the clinical outcome postoperative infection.
All tests were two tailed; p< .05 was considered significant. Data were analyzed using statisti-
cal software (Statistical Package for Social Sciences, Version 20 for Macintosh; SPSS; Chicago,
Illinois).
Results
Baseline characteristics and outcome of the study population
Baseline characteristics of the whole study population are given in Table I. The median age of
the patients was 66.5 years. Of these, 27% were female. The median length of hospital stay was
8.5 days. A total of 20 patients (16.7%) had known diabetes mellitus II. Overall, 40 patients
Table I. Patient- and surgery-related characteristics (n = 120).
Age in years (median, IQR) 66.5 (54.2–75.0)
Gender male/female (n, %) 88/32 (73%/27%)
BMI in kg/m2 (median, IQR) 26.3 (23.6–30.4)
Diabetes mellitus yes/no (n, %) 20/100 (16.7%/83.3%)
EuroScore II (median, IQR) 3.1% (1.5%- 5.3%)
HLM yes/no (n, %) 93/27 (77.5%/22.5%)
Time of ECC in min (mean, SD) 143.7 ± 56.6
Time of ischemia in min (mean, SD) 97 ± 45
Total time of surgery in min (mean, SD) 245.6 ± 105
Total stay in ICU in hours (median, IQR) 23 (19–40.5)
Total stay in hospital in days (median, IQR) 8.5 (7–12)
Type of operation (n, %)
Isolated CABG 40 (33.3%)
Isolated valve replacement/reconstruction 41 (34.2%)
Isolated aortic surgery 1 (0.8%)
Combined surgery 26 (21.7%)
Others 12 (10.0%)
Surgical approach (n, %)
Sternotomy 97 (80.8%)
Mini thoracotomy 17 (14.2%)
Others 6 (5.0%)
Infection yes/no (n, %) 18/102 (15%/85%)
Pneumonia (n, %) 8 (44.4%)
Urinary tract infection (n, %) 3 (16.6%)
Peripheral wound infection (n, %) 4 (22.2%)
Sternal wound infection (n, %) 2 (11.1%)
Mediastinitis (n, %) 1 (5.6%)
Sepsis yes/no (n, %) 3/117 (2.5%/97.5%)
Mortality yes/no (n, %) 1/119 (0.8%/99.2%)
SD = standard deviation
IQR = interquartile range
doi:10.1371/journal.pone.0120276.t001
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(33.3%) received isolated coronary artery bypass grafting (CABG) while 41 patients (34.2%) re-
ceived isolated valve surgery (including replacement and reconstruction of the aortic or mitral
valve). In the former group, 22.5% of surgery was undertaken without the use of cardiopulmo-
nary bypass (off-pump). In 26 patients (21.7%), combined heart surgery including CABG and
valve surgery was performed. Among the entire study population, in 17 patients (14.2%) a min-
imally invasive surgical technique was employed. The median stay in the ICU was 23 hours. In
the ICU, 95% of patients were in need of vasopressors signifying the presence of some degree
of SIRS in the vast majority of patients. The early postoperative course was uneventful in 102
(85%) patients while a diagnosis of infection was established in 18 patients (15%). Of these, 3
patients fulfilled the current diagnostic criteria of sepsis. In the great majority of patients, the
focus of infection was either in the urinary or respiratory tract with a minority of patients suf-
fering from peripheral wound infection. There were two documented cases of sternal wound
infections and one patient was diagnosed with mediastinitis. One patient died in the ICU sec-
ondary to postoperative heart failure resulting in an overall mortality rate of 0.8%.
Fig 1. Association of PSP, CRP andWBC levels with age (A), gender (B) and diabetes (C). Shown are
values at baseline (preoperative values). The groups were compared by one-way ANOVA. Asterisks indicate
significant differences (*p<0.05; **p<0.01).
doi:10.1371/journal.pone.0120276.g001
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Association between inflammatory markers and baseline characteristics
Serum levels of biomarkers are shown in Fig. 1. Of note, at baseline PSP was significantly
higher in patients with diabetes mellitus II as opposed to non-diabetic study participants
(p = 0.008). There was no correlation between PSP levels and adiposity (BMI>30) (p = 0.324).
However, PSP levels were significantly higher in elderly patients above the median age of 67
years (p = 0.01). The difference of PSP among diabetic patients lost statistical significance after
adjusting for age. There was no significant difference in the distribution of WBC and CRP lev-
els in elderly or diabetic patients.
Time course of inflammatory markers in patients after cardiac surgery as
related to postoperative infection and sepsis
Univariate analysis using a linear mixed effects regression model showed a statistically signifi-
cant increase of PSP levels within 72 h following cardiac surgery (p< 0.05) in the entire study
population (Fig. 2). Similarly, canonical pro-inflammatory markers such as WBC and CRP in-
creased markedly with 72 h after cardiac surgery (p<0.001 for CRP, p<0.001 for WBC) (Fig. 2);
in the postoperative distribution of PSP levels, there was a significant interaction between devel-
oping an infection and time, signifying a significantly steeper increase in PSP levels in patients
developing infection as opposed to those exhibiting an uneventful course (p value for interaction
= 0.02) (Fig. 3). However, neither of the other parameters had the ability to differentiate infec-
tion from surgical inflammation (p-value for interaction = 0.4 for WBC and 0.29 for CRP)
(Fig. 3). In order to further substantiate the discriminatory power of PSP to detect the presence
of infection, we employed a multivariate split plot ANOVA design adjusting for age and diabe-
tes. While CRP andWBC again lacked any discriminatory power in identifying the presence of
infection, PSP levels proved to be significantly higher in patients with infection in the adjusted
analysis (p = 0.015). In the cohort of patients with postoperative infection, there were three
cases fulfilling the criteria of sepsis as outlined above. Again, employing univariate analysis, PSP
levels were significantly higher in septic patients during 72 hours following cardiac surgery as
opposed to patients exhibiting an uneventful postoperative course (p = 0.001) while CRP and
WBC levels were increased irrespective of the absence or presence of infection. To underline the
role of PSP in differentiating infection PSP levels in patients requiring postoperative antibiotics
are shown in comparison to those with an uneventful course (S1 Fig.).
Association of biomarkers with type of surgery
Focusing on patients undergoing off-pump surgery in comparison to those exposed to cardio-
pulmonary bypass (on-pump surgery), there was no significant difference in PSP, CRP or
Fig 2. Time course of biomarkers (A-C) following cardiac surgery. All inflammatory markers investigated showed a statistically significant rise in the
course of postoperative day 1–3 (p<0.05, determined by a linear mixed effects regression model).
doi:10.1371/journal.pone.0120276.g002
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WBC levels at postoperative day 1–3 (p>0.05 for all biomarkers) (Fig. 4). To look more closely
on the impact of surgical trauma as related to postoperative dynamics of the biomarkers, we
stratified patients according to type of surgery (minimally invasive approach versus sternot-
omy). Patients undergoing sternotomy had a significantly steeper rise of postoperative PSP
(p0.001) as opposed to those subjected to a minimally invasive approach. The type of surgical
technique had no significant impact on the postoperative distribution on CRP andWBC levels
(p>0.05) (Fig. 5).
Association of PSP levels with clinical outcomes
To further corroborate the potential predictive ability of PSP for the presence of infection in
cardiac surgery patients, we employed ROC curve analysis for PSP at postoperative day 1–3.
Fig. 6 illustrates the ROC curves and indicates the area under curve for PSP, WBC and CRP.
The highest sensitivity and specificity was achieved by PSP at postoperative day 2 (AUC =
0.765, CI = 0.621–0.877). Traditional inflammatory markers showed basically no predictive
ability for infection (AUC for CRP at postoperative day 2 = 0.534, AUC for WBC at postopera-
tive day 2 = 0.641). Giving equal weight to both sensitivity and specificity, we selected 48.1ng/
ml for PSP. With this cutoff point we were able to predict yet clinically unapparent postopera-
tive infection at postoperative day 2. Moreover, in univariate logistic regression analysis PSP at
Fig 3. Discriminatory power of biomarkers for postoperative infection. PSP levels showed a
significantly stronger postoperative rise at day 1–3 in patients receiving a diagnosis of infection during their
hospital stay as opposed to patients exhibiting an uneventful course. (p<0.05 for interaction, determined by a
linear mixed effects regression model). Other biomarkers (CRP andWBC) failed to differentiate infection from
postoperative inflammatory power.
doi:10.1371/journal.pone.0120276.g003
Fig 4. Time course of biomarkers as related to the absence or presence of cardiopulmonary bypass.
All inflammatory markers investigated showed a steeper rise in patients subjected to cardiopulmonary
bypass without reaching statistical significance. (p>0.05 for interaction for all biomarkers, determined by a
linear mixed effects regression model).
doi:10.1371/journal.pone.0120276.g004
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day 2 significantly predicted the clinical outcome postoperative infection (OR = 2.5, p = 0.001),
while canonical biomarkers for infection (WBC, CRP) lacked any discriminatory ability in
this regard.
Discussion
In this pilot study, our aim was to investigate the diagnostic accuracy of PSP for the presence of
postoperative infections in an unselected cohort of patients undergoing cardiac surgery. Al-
though substantial evidence points towards a potential value of PSP as a novel sepsis biomarker
with the ability to identify and risk-stratify patients in a broad range of clinical spectra, its role
in surgical patients remains unclear. Of note, cardiac surgery entailing the use of cardiopulmo-
nary bypass was repeatedly associated with some degree of systemic inflammation, which is re-
flected by an increase in circulating levels of pro-inflammatory biomarkers and clinical picture
resembling septicemia [19]. Consequently, it is particularly challenging to establish a diagnosis
of infection beyond reactive inflammation secondary to surgical stress in the postoperative set-
ting. In the present study, we found a significant rise in the levels of both PSP and canonical in-
flammatory markers (CRP, WBC) following cardiac surgery. However, there was a significant
rise of PSP levels in patients diagnosed with infection during their postoperative course over
the following 72 h compared to those whose postoperative course was uneventful. Importantly,
the same aforementioned time course of inflammatory markers was observed irrespective of
the use of cardiopulmonary bypass. Concerning the surgical technique (sternotomy versus
Fig 5. Time course of biomarkers as related to the surgical technique employed. PSP levels showed a
significantly steeper rise in the postoperative course of patients subjected to sternotomy compared to those
receiving minimally invasive surgery (p<0.05 for interaction, determined by a linear mixed effects regression
model). There was no significant difference in the postoperative levels of CRP andWBC between the two
cohorts of patients.
doi:10.1371/journal.pone.0120276.g005
Fig 6. Receiver operating characteristics curve to predict infection for PSP (A), CRP (B) andWBC (C)
at postoperative 1–3. A cutoff of 48.1 ng/ml for PSP levels at postoperative day 2 reveals a sensitivity of
64% and a specificity of 70%. PLR (positive likelihood ratio) = 2.1. NLR (negative likelihood ratio) = 0.51.
doi:10.1371/journal.pone.0120276.g006
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minimally invasive approach), we found a significant difference in the slope of postoperative
PSP values with a markedly steeper increase in those exposed to sternotomy. However, PSP re-
tained its ability to detect infection in the entire cohort studied. Overall, these data suggest that
although surgical trauma has a significant impact on PSP levels, the slope of the rise in PSP lev-
els more specifically mirrors infectious conditions above a reactive increase of this secretory
protein upon surgical trauma. Canonical inflammatory markers such as circulating levels of
CRP and WBC, on the other hand, appear to primarily reflect surgical trauma, without en-
abling identification of the presence of infection and cannot be used for determining the pres-
ence or absence of infection. It should be emphasized that the exact origin and essential
triggers for PSP release are far from clear. Previous studies suggest that PSP plays a role in acti-
vating neutrophils and aggregating bacteria. Of note, PSP has been demonstrated to bear a
high degree of structural homology with lectins suggesting an as yet under-appreciated role for
PSP during bacterial infection [20]. Consistent with this finding, the obervation of a much
steeper rise of PSP in patients suffering postoperative infection provides further evidence for a
role of PSP as a predictor of infection at incipient stages of the disease. Although initially iden-
tified in pancreas-derived calcified concrements [21], in the last few years it became increasing-
ly evident that PSP is expressed in a much broader variety of tissues including the stomach and
small intestine [22]. Previous studies demonstrated that levels of expression of PSP are drasti-
cally increased in response to various types of inflammatory conditions in the absence of acute
pancreatitis. Compared to traditional biomarkers of inflammation (such as WBC and CRP),
PSP emerged not only as a promising biomarker for sepsis but also as a predictor for clinical
outcomes including sepsis or death at the ICU [23]. This finding ties in well with our finding of
PSP primarily reflecting infection rather than non-infectious states of systemic inflammation.
Previous studies mainly focused on the role of PSP with regard to infection and its predictive
power for clinical outcomes in septic patients. However, it remained unclear whether the in-
creased PSP levels were due to activation of infection pathways or rather serve as a surrogate
parameter for tissue hypoperfusion [24]. Given that cardiopulmonary bypass is inevitably asso-
ciated with some degree of unfavorable tissue perfusion our finding of PSP levels showing a
similar time course in both the off-pump and on-pump setting clearly suggests that non-
infectious systemic inflammation is associated with only a moderate rise in PSP levels [25]. The
presence of clinically overt infection, however, was associated with a marked increase in PSP ir-
respective of preceding surgical trauma. Given that 75% of study participants were in need of
postoperative vasopressors, it can be assumed that a large majority of patients indeed suffered
from some degree of postoperative inflammatory trauma. Consequently, in our study PSP re-
tained discriminatory power for infection even against the background of sterile systemic in-
flammation. This finding could be confirmed by various approaches of statistical analysis
(linear mixed effects model, split-plot ANOVA). In this study, we employed 3 consecutive
measurements of postoperative PSP levels at 24 h, 48 h and 72 h. A closer look at the time
course of PSP shows that the curves deviate already after 24 h with a peak of PSP after 48 h in
patients with postoperative infection. After 72 h, there was no further increase of PSP levels. Al-
together, it would appear that a time frame between 24 h and 48 h following cardiac surgery
would be ideal for early diagnosis of infection, as yet clinically unapparent, in cardiac surgery
patients and associated reactive inflammation.
ROC curve analysis showed the greatest sensitivity and specificity at 48 h in the postopera-
tive course, with a cut-off point of 48.1 ng/L for the clinical outcome infection. Although PSP
performed best among the inflammatory markers investigated given the rather moderate AUC,
the overall discriminatory power in terms of increasing the post-test probability for infection
remains suboptimal. Another important observation relates to the association of age and diabe-
tes with baseline PSP values. Elderly patients (above the median age of 67 years) were found to
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have significantly higher PSP levels at baseline than their younger counterparts. A similar ob-
servation could be made in patients with suspected or established diabetes mellitus [26]. The
relevance of age as well as the impact of age-related comorbidities on PSP levels need to be in-
vestigated in future clinical trials. The finding of an association of PSP levels with diabetic sta-
tus suggests a pro-inflammatory state in this cohort of patients, which is in agreement with
previous studies. However, PSP proved of value for predicting infection in the entire cohort
studied independent of a diagnosis of diabetes at baseline. There are further limitations of the
study. First of all, our pilot study on the time course of PSP in cardiac surgery patients and its
relationship with clinically apparent infection needs to be considered as hypothesis generating
and awaits confirmation in future studies. Moreover, given the single-center design of our
study, there is no external validation of our data. In this study, it was our aim to enroll an unse-
lected cohort of cardiac surgery patients to capture the real-life setting as closely as possible.
However, given the small sample size, it was not feasible to control for multiple baseline and
surgery- related characteristics, and to elucidate the time course of postoperative PSP levels as
related to the type of infection. Consequently, the impact of different comorbidities on PSP lev-
els at baseline as well as in the postoperative course remains unclear. In future trials, a major
focus should be put on the impact of potential clinical confounders on the distribution of PSP
levels. Nevertheless, our study corroborates the potential of PSP to differentiate bacterial infec-
tion from reactive inflammation in a cohort of patients subjected to a substantial degree of in-
flammatory stimulation and hence underpins the clinical relevance of this novel biomarker for
detection of infection in cardiac surgery patients. Given the high morbidity associated with a
postoperative course of cardiac surgery complicated by infection, biomarkers that enable early
clinical decision making in this cohort of patients are clearly warranted.
Overall, we conclude that levels of PSP at postoperative day 1–3 possess discriminatory
properties for infection in the context of an unselected cohort of patients undergoing cardiac
surgery. This finding is evident irrespective of the surgical technique or use of cardiopulmonary
bypass. Consequently, PSP is poised well as a promising biomarker at the crossroads of reactive
inflammation and infection. However, at present, thorough clinical assessment of patients by
an experienced and preferably multidisciplinary team remains the mainstay in the evaluation
of patients deemed at risk for sepsis. Future clinical studies are required to further assess
whether PSP has a future role in clinical decision making in the postoperative course of cardiac
surgery patients.
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